 |
Video: What is a Stock Split?
|
 |
iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. Co. develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu technology is an AI-based tool designed to predict a library of antibodies with fully human Complementarity-Determining Region (CDR) variants based on an input antibody. Its pre-clinical pipeline of immuno-oncology targets the treatment of solid tumors, glioblastoma, head, and neck cancers. According to our IBIO split history records, iBio has had 3 splits. | |
 |

iBio (IBIO) has 3 splits in our IBIO split history database. The first split for IBIO took place on June 11, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of IBIO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. IBIO's second split took place on October 10, 2022. This was a 1 for 25 reverse split, meaning for each 25 shares of IBIO owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 4 share position following the split. IBIO's third split took place on November 29, 2023. This was a 1 for 20 reverse split, meaning for each 20 shares of IBIO owned pre-split, the shareholder now owned 1 share. For example, a 4 share position pre-split, became a 0.2 share position following the split.
When a company such as iBio conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the IBIO split history from start to finish, an original position size of 1000 shares would have turned into 0.2 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into iBio shares, starting with a $10,000 purchase of IBIO, presented on a split-history-adjusted basis factoring in the complete IBIO split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/23/2015 |
|
End date: |
06/20/2025 |
|
Start price/share: |
$5,050.00 |
|
End price/share: |
$0.77 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.98% |
|
Average Annual Total Return: |
-58.47% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1.53 |
|
Years: |
10.00 |
|
|
 |
Date |
Ratio |
06/11/2018 | 1 for 10 | 10/10/2022 | 1 for 25 | 11/29/2023 | 1 for 20 |
|
 |